Background. In treating malaria in Uganda, artemether-lumefantrine (AL) has been
associated with a lower risk of recurrent parasitemia, compared with artesunate …

Background Case management based on prompt diagnosis and adequate treatment using
artemisinin-based combination therapy (ACT) remains the main focus of malaria control in …

Background The use of artemisinin-based combination therapy (ACT) as first-line treatment
for uncomplicated malaria was a policy recommended by World Health Organization. In …

Introduction Several studies conducted in African countries reported the artesunate and
amodiaquine (AS/AQ) tablet as a safe and well-tolerated anti-malarial drug in children and …

Objectives The involvement of pharmacists is very important in achieving the goals of
therapeutic management of malaria. This study aimed to analyse the profile of pharmacist …

The emergence of Plasmodium falciparum strains (multidrug resistant) resistant to
commonly used antimalarial agents has motivated the research for novel drugs and drug …

Introduction: Amodiaquine is a partner drug in the artemisinin-based combination therapy
artesunate-amodiaquine. Reports of the adverse drug reaction known as amodiaquine …

The influence of body weights on Plasmodium falcifarum clearance in malaria positive
children was conducted using AT+ SP and AQ+ SP combination therapies, at the malaria …

The purpose of this study is to summarize the available data on the efficacy of Artesunate
plus Amodiaquine (AS+ AQ) versus Artemether-Lumefantrine (AL) for the treatment of …

Objectives The involvement of pharmacists is very important in achieving the goals of
therapeutic management of malaria. This study aimed to analyse the profile of pharmacist …